No retraction, correction or concern found when last checked on Oct 18, 2026.
Distinct evolutionary dynamics of horizontal gene transfer in drug resistant and virulent clones of Klebsiella pneumoniae
Kelly L. Wyres, Ryan R. Wick, Louise M. Judd and 7 more
PLOS Genetics · 2019 · CC BY
Abstract
Klebsiella pneumoniae has emerged as an important cause of two distinct public health threats: multi-drug resistant (MDR) healthcare-associated infections and drug susceptible community-acquired invasive infections. These pathotypes are generally associated with two distinct subsets of K. pneumoniae lineages or 'clones' that are distinguished by the presence of acquired resistance genes and several key virulence loci. Genomic evolutionary analyses of the most notorious MDR and invasive community-associated ('hypervirulent') clones indicate differences in terms of chromosomal recombination dynamics and capsule polysaccharide diversity, but it remains unclear if these differences represent generalised trends. Here we leverage a collection of >2200 K. pneumoniae genomes to identify 28 common clones (n ≥ 10 genomes each), and perform the first genomic evolutionary comparison. Eight MDR and 6 hypervirulent clones were identified on the basis of acquired resistance and virulence gene prevalence. Chromosomal recombination, surface polysaccharide locus diversity, pan-genome, plasmid and phage dynamics were characterised and compared. The data showed that MDR clones were highly diverse, with frequent chromosomal recombination generating extensive surface polysaccharide locus diversity. Additional pan-genome diversity was driven by frequent acquisition/loss of both plasmids and phage. In contrast, chromosomal recombination was rare in the hypervirulent clones, which also showed a significant reduction in pan-genome diversity, largely driven by a reduction in plasmid diversity. Hence the data indicate that hypervirulent clones may be subject to some sort of constraint for horizontal gene transfer that does not apply to the MDR clones. Our findings are relevant for understanding the risk of emergence of individual K. pneumoniae strains carrying both virulence and acquired resistance genes, which have been increasingly reported and cause highly virulent infections that are extremely difficult to treat. Specifically, our data indicate that MDR clones pose the greatest risk, because they are more likely to acquire virulence genes than hypervirulent clones are to acquire resistance genes.
Full text
From PubMed Central, U.S. National Library of Medicine, as current on Oct 18, 2026. Paragraph numbers are ours, so an answer can point at one.
Introduction
Klebsiella pneumoniae is most well known as an opportunistic hospital pathogen for which multi-drug resistance (MDR) is a major global public health concern. However, this bacterium has also emerged as an important cause of community acquired invasive disease, often manifesting as liver abscess with bacteraemia and usually susceptible to antimicrobials. The K. pneumoniae population is extemerly diverse, comprising 100s of independent phylogenetic lineages or ‘clones’ that differ from each other by ~0.5% nucletide divergence. The majority of MDR hospital outbreaks are caused by a small subset of K. pneumoniae clones with a high prevalence of acquired antimicrobial resistance (AMR) genes, while the majority of community-acquired invasive infections are caused by ‘hypervirulent’ clones that rarely harbour acquired AMR genes but have high prevalence of key virulence loci.
In K. pneumoniae MDR evolution is largely driven through acquisition of AMR genes on diverse mobilisable plasmids which are particularly prevalent among the global hospital outbreak clones; e.g. clonal group (CG) 258 which is implicated in global spread of the K. pneumoniae carbapenemases. K. pneumoniae pathogenicity is driven by a wide array of interacting factors that are present in all strains, including the type III fimbriae (mrk) and the surface polysaccharides (capsule and lipopolysaccharide (LPS)) which exhibit antigenic variation between strains. The majority of hypervirulent K. pneumoniae, distinguished clinically as causing invasive infections even outside the hospital setting, are associated with just two of the >130 predicted capsular serotypes, K1 and K2, that are considered particularly antiphagocytic and serum resistant. Hypervirulent K. pneumoniae are also associated with high prevalence of several other key virulence factors; the rmpA/rmpA2 genes that upregulate capsule expression to generate hypermucoidy; the colibactin genotoxin that induces eukaryotic cell death and promotes invasion to the blood from the intestines; and the yersiniabactin, aerobactin and salmochelin siderophores that promote survival in the blood by enhancing iron sequestration.
Yersiniabactin synthesis is encoded by the ybt locus, which is usually mobilised by an integrative, conjugative element known as ICEKp. It is present in ~40% of the general K. pneumoniae population and seems to be frequently acquired and lost from MDR clones. Fourteen distinct ybt+ICEKp variants are recognised, one of which also carries the colibactin synthesis locus (clb). In contrast, the salmochelin (iro), aerobactin (iuc) and rmpA/rmpA2 loci are usually co-located on a virulence plasmid. These loci are much less common in the K. pneumoniae population (<10% prevalence each) and until recently were rarely reported among MDR strains.
The reasons for the apparent separation of MDR and hypervirulence are unclear but there are growing reports of convergence from both directions, i.e. hypervirulent strains gaining MDR plasmids and MDR strains gaining a virulence plasmid plus/minus an ICEKp. Most such reports are sporadic, but in 2017 Gu and colleagues described a fatal outbreak of MDR, carbapenem-resistant K. pneumoniae belonging to CG258 that had acquired ICEKp in the chromosome plus iuc and rmpA2 on a virulence plasmid. The report fuelled growing fears of an impending public health disaster in which highly virulent MDR strains may be able to spread in the community, causing dangerous infections that are extremely difficult to treat. However, there remain significant knowledge gaps about K. pneumoniae evolution that limit our ability to understand the severity of this public health threat, and to evaluate the relative risks of convergence events.
The vast majority of clonal evolutionary analyses have focussed on a single MDR clone, CG258, revealing an evolutionary history peppered by chromosomal recombination events, extensive capsule locus diversity and acquisition of diverse AMR genes on diverse plasmids (summarised in). Few studies have explored the genomic evolution of other clones, but our recent study of hypervirulent CG23 highlighted intriguing differences; i) chromosomal recombination and plasmid acquisition were comparatively rare and; ii) a single capsule locus and the virulence plasmid were both maintained for >100 years.
Here we report the first comprehensive comparison of genome evolutionary dynamics in multiple K. pneumoniae clones. We leveraged a curated collection of >2200 K. pneumoniae genomes to identify 28 common clones with at least 10 genomes in each. We characterised each clone in terms of its resistance and virulence gene content, and surface polysaccharide diversity. We also performed chromosomal recombination and pan-genome analyses, revealing key differences in horizontal gene transfer dynamics.
Definition of hypervirulent and MDR clones
A total of 28 common K. pneumoniae clones were identified from our collection of 2265 K. pneumoniae genomes as described in Methods (total 1092 genomes, 10–266 genomes per clone, see Fig 1A and 1B, S1 and S2 Tables). The majority (87.6%) represented human clinical or carriage isolates from a range of geographies and years, such that ≥3 geographic continents and ≥6 years of time were represented within each clone (S1 Fig). Unless otherwise stated, there were no statistically significant associations between features of the genome sample for each clone (including sample size, median evolutionary divergence, or geographic diversity) and results of the genomic analyses discussed hereafter (see S1 Text, S3 Table, and Fig 2A as discussed below).
For each clone, the proportion of genomes harbouring the key virulence and AMR loci were calculated (Fig 1C). Hierarchical clustering of the virulence locus data were used to define a group of 6 hypervirulent clones including the previously described CG23, CG86 and CG65, each of which harboured the virulence plasmid-associated genes iuc, iro and/or rmpA/rmpA2 at high frequency (31–100%). Hierarchical clustering of the AMR data were used to define a group of 8 MDR clones, including the outbreak associated CG258, CG15 and CG147, each with a high frequency (≥56%) of genomes encoding acquired resistance determinants for ≥3 drug classes (in addition to ampicillin to which all K. pneumoniae share intrinsic resistance via the chromosomally encoded SHV-1 beta-lactamase, equivalent to the standard definition of MDR as described in). As expected, AMR genes were rare among the hypervirulent clones, with the exception of CG25 in which 11 of 16 genomes harboured ≥4 acquired AMR genes. The iuc, iro and rmpA/rmpA2 loci were rare (<12% frequency) among the MDR clones and those not assigned to either group (‘unassigned’ clones); however, the ybt locus was frequently identified across the spectrum of clones as has been reported previously.
This asymmetric distribution of virulence plasmid-associated virulence loci (iro, iuc and rmpA/2) with AMR determinants is in accordance with general trends seen across the wider K. pneumoniae population wherein the presence of the virulence plasmid (with or without ICEKp) is negatively associated with the presence of acquired AMR genes: Among a broad, representative genome sample (n = 1124, see Methods) the majority (n = 77/88) of genomes harbouring the virulence plasmid contained 0–1 acquired AMR genes, while the distributions were much broader for genomes without the virulence plasmid plus/minus ICEKp (median 1, interquartile range (IQR) 0–9, p < 1x10-10 for both pairwise Wilcoxon Rank Sum tests). Among the genomes without the virulence plasmid the distribution of acquired AMR genes was slightly shifted towards higher numbers in genomes harbouring ICEKp (median 1 vs 1, IQR 0–8 vs 0–10, p < 1x10-8; see S2 Fig).
The capsule and LPS synthesis loci are recombination hot-spots in MDR but not hypervirulent clones
We used Gubbins to identify putative chromosomal recombination imports within each clone and calculated nucleotide divergence for all pairs of genomes within clones before and after the removal of recombinant sequence regions (S3 Fig). Median pairwise nucleotide divergence ranged from 0.003% to 0.355% prior to recombination detection and from 0.002% to 0.251% after recombination detection. The data indicated that recombination has significantly influenced within-clone nucleotide diversity for all clone types (Fig 2A), with particularly strong influence on the unassigned and MDR clones compared to the hypervirulent clones (pairwise Wilcoxon Rank Sum tests for difference in nucleotide diversity after recombination removal; MDR and unassigned, p < 1x10-15; hypervirulent, p = 0.0004). Notably, within-clone nucleotide divergence differed by clone type, both prior and following the removal of recombinant regions (Kruskal-Wallis test, p < 1x10-15). Importantly, these data showed that our sample captured less nucleotide divergence due to accumulation and vertical inheritance of substitution mutations among the MDR than hypervirulent clones (median pairwise divergence after removal of recombinant regions; 0.003% vs 0.005%, p < 1x10-15 by Wilcoxon Rank Sum test). Nucleotide divergence through ancestral descent is generally considered to be correlated with evolutionary time, and these observations are consistent with recent molecular dating analyses estimating that MDR CG258 emerged in the mid 1980s while hypervirulent CG23 emerged more than 100 years earlier, in the late 1800s. Notably, the hypervirulent clone isolates were also collected over a longer time period (S1 Fig).
We next calculated r/m (the ratio of single nucleotide variants introduced by homologous recombination relative to those introduced by substitution mutations), which ranged from 0.02–25.50 (Fig 2B, S1 Table). With the exception of CG25, the hypervirulent clones generally exhibited lower r/m values (median 1.15), while the MDR clones trended towards higher values (as may be expected from comparison of the pairwise divergence distributions, median 5.47), although the differences were not statistically significant (Kruskall-Wallis test p = 0.07).
Recombination events were not evenly distributed across chromosomes: in 19/28 clones ≥50% of the chromosome was not subject to any recombination events, while the maximum recombination load in each clone ranged from mean 1.1–47.6 events (Fig 3A and 3B, S4 Fig). In many cases there was a major peak defining a recombination hot-spot at the capsule (K) and adjacent LPS antigen (O) biosynthesis loci (see e.g. CG34 and CG258 in Fig 3A, and S4 Fig). Among the 17 clones with ≥1 detectable recombination hotspot (arbitrarily defined as mean recombination count of ≥5 per base calculated over non-overlapping 1000 bp windows), the galF K locus gene was ranked among the top 2% recombination counts in 16 clones (Fig 3B and S4 Fig). Consistent with these findings, 20 clones were associated with ≥3 distinct K loci and 11 clones were also associated with ≥3 O loci (Fig 3C, S5 and S6 Figs). The absolute numbers of K and O-loci per clone were significantly associated with sample size (p < 1x10-4 and p = 0.0157, respectively), but this was not the case for the respective diversity metrics shown in Fig 3C (effective Shannon diversity, p = 0.259 and p = 0.56). Therefore the data indicate that the capsule and LPS are subject to strong diversifying selection and that the greater the number of samples, the greater the likelihood of capturing additional K or O loci. However, this was not the case for the hypervirulent clones, which were associated with low K and O locus diversity: five out of the six had just one K and one O locus type (either KL1 or KL2, plus O1/O2v1 or O1/O2v2) and showed no evidence of recombination events affecting galF (Fig 3B and 3C, S5 and S6 Figs).
The key selective drivers for K/O locus diversity are not known. The role of the mammalian immune system is unclear because K. pneumoniae are opportunistic rather than obligate human pathogens that can inhabit a range of host-associated niches and live ubiquitously in the environment. Mammalian gastrointestinal carriage of K. pneumoniae is common, and may provide some immune exposure favouring capsule diversity. However, phage and/or protist predation likely also play a role. Numerous capsule specific K. pneumoniae phage have been reported and ecological modelling supports a key role for phage-induced selective pressures in maintaining surface polysaccharide diversity in free-living bacteria.
In either scenario, the relative lack of capsule diversity among the hypervirulent clones may suggest that they are not subject to the same selective pressures, perhaps indicating some sort of ecological segregation e.g. preference for host- vs non-host associated environments, for different hosts or differences in the duration of host carriage. In particular, given the incidence of disease we might predict that hypervirulent clones are carried in the human gastrointestinal tract less frequently and/or for shorter duration than MDR clones. This possibility is intriguing and could explain the separation of hypervirulence and MDR, by limiting opportunities for horizontal gene transfer between MDR and hypervirulent clones. Isolates representing both clone types have been identified among diverse host-associated niches including the human gastrointestinal tract but it is not possible to determine any particular ecological preference or differences in carriage duration due to the lack of systematic sampling efforts to-date. An alternative explanation is that the hypervirulent clones are subject to some sort of mechanistic limitation for chromosomal recombination, that in turn limits surface polysaccharide diversity and the acquisition of other chromosomally encoded accessory genes, as have recently shown to be frequently acquired by CG258 strains. If so, we may also expect a general trend towards lower gene content diversity in the hypervirulent clones.
Hypervirulent clones are associated with low pan-genome diversity
To assess overall gene content diversity we conducted a pan-genome analysis using Roary. Given the evidence that our hypervirulent clones represented a greater amount of evolutionary divergence than the MDR clones (Fig 2A), we might expect these clones to harbour comparatively greater gene content diversity. Contrary to this expectation, pairwise Jaccard gene content distances were generally lower for genome pairs within hypervirulent clones than the MDR or unassigned clones, suggesting the former have less diverse pan-genomes than expected (p < 1x10-15 for each pairwise Wilcoxon Rank Sum test, Fig 4A, S7A Fig). Supporting this trend, the hypervirulent clones were associated with comparatively shallow pan-genome accumulation curves (Fig 4B). In order to quantify the differences in these curves we fitted the pan-genome model proposed by Tettelin and colleagues, and derived an alpha value for each clone (S1 Table), whereby values <1 indicate an open pan-genome and >1 indicate a closed pan-genome. Consistent with previous data showing extensive gene content diversity within the K. pneumoniae species, the majority of clones had alpha values below 1. The exceptions were hypervirulent clones CG380, CG66 and CG25 plus MDR clone CG231, however we note that the standard error of these estimates ranged from 0.25 to 0.65. There was a trend towards higher alpha values (i.e. less open) among the hypervirulent clones (median alpha = 0.91, IQR 0.71–1.07), in comparison to the unassigned clones (median alpha = 0.53, IQR 0.51–0.58, p = 0.0033) and the MDR clones (median alpha = 0.68, IQR 0.67–0.76, p = 0.345) (Fig 4B), but only the former was significant.
It is well known that large groups of accessory genes can be linked on the same mobile element (e.g. large conjugative MDR plasmids that are common in the MDR clones, or the virulence plasmids characteristic of the hypervirulent clones), so a single gain or loss event may have a large effect on gene-based measures such as pairwise Jaccard distances and accumulation curves. Hence we used a principal component analysis (PCA) to generate a metric that is less sensitive to the correlation structure in the gene content data (see Methods). The PCA transformed the accessory gene content matrix comprising 1092 genomes vs 39375 genes into coordinates in a 463-dimensional space. These 463 axes accounted for 95% of the variation in the data and were used to calculate the Euclidean distance of each genome to its clone centroid. The resulting distributions of distances provided further support that the MDR and unassigned clones display greater gene content variation than hypervirulent clones (Fig 4C; p < 1x10-15, 2 d.f., Kruskal-Wallis test; p < 1x10-15 for each pairwise Wilcoxon Rank Sum test) and suggest this is associated with a greater frequency of horizontal gene transfer events rather than a similar number of events introducing larger changes in gene content. In addition, the putative ancestry of accessory genes (see Methods) was more diverse among MDR and unassigned clones than the hypervirulent clones, supporting that the latter are subject to a more limited range of partners for horizontal gene transfer (Wilcoxon Rank Sum tests: hypervirulent vs MDR, p = 0.0027; hypervirulent vs unassigned, p = 1x10-4; MDR vs unassigned, p = 0.38; Fig 4D, S1 Table).
The data suggest that the unassigned clones may harbour slightly greater gene content diversity than the MDR clones (median pairwise Jaccard distance 0.1574 vs 0.1464, p < 1x10-15; median Euclidean distance 18.01 vs 17.26, p = 0.0083; alpha values 0.53 vs 0.68, p = 0.0064), which may indicate that the former inhabit a more generalist niche than the MDR clones e.g. inhabit a greater variety of hosts, or that the MDR clone samples represent more recent clonal expansions. The latter is consistent with the lower nucleotide divergence captured in the MDR compared to the unassigned clones (Fig 2A), although we note that our analysis did not support nucleotide divergence as a major driver of differences in gene content variation (S1 Text and S3 Table).
Plasmid and phage diversity differs between clones
To further explore differences in common sources of accessory gene diversity, we assessed phage and plasmid diversity. For each genome we summed the length of genomic regions identified as phage by VirSorter (range 0–221 kbp, S2 Table) and used a PCA of phage-associated gene content to calculate distance to clone centroids as for the total pan-genome (Fig 5A and 5B and S8 Fig). Hypervirulent clones showed similar phage load and slightly reduced diversity compared to the unassigned clones (Fig 5A and 5B; Wilcoxon Rank Sum tests, hypervirulent vs unassigned: load, p = 0.15; diversity, p = 0.0165). MDR clones were associated with higher load and diversity than both the hypervirulent and unassigned groups (p < 1x10-15 for each pairwise comparison). Although these analyses were dependent on the quality and breadth of the underlying viral sequence database which may be subject to species bias, we have no reason to expect that this would be skewed with respect to MDR over hypervirulent clones. Hence it is clear that K. pneumoniae, and in particular the MDR clones, are subject to frequent attack by diverse phage.
Unfortunately it is not possible to reliably identify plasmid sequences from draft genome assemblies. Instead we used plasmid replicon and relaxase (mob) typing as indicators of plasmid load and diversity. Each genome contained 0–12 of 69 uniquely distributed replicon markers and 0–23 mob-positive assembly contigs (detected by screening against the PlasmidFinder database and mob PSI-BLAST, respectively; S2 Table). MDR and unassigned genomes harboured a greater number of replicon markers than hypervirulent genomes, largely driven by low replicon loads in CG23 that was overrepresented among the hypervirulent genomes (Fig 5C and 5D and S9 Fig; Wilcoxon Rank Sum tests: hypervirulent vs unassigned, p = 1.5×10−4; MDR vs unassigned, p < 1x10-15; MDR vs hypervirulent, p < 1x10-15). There were no significant differences between the hypervirulent and unassigned groups for counts of mob-positive contigs per genome, and comparatively small differences between the MDR and unassigned or hypervirulent groups (Wilcoxon Rank Sum test: MDR vs unassigned, p = 1x10-6; MDR vs hypervirulent, p <1x10-6, S9 Fig).
Comparison of effective Shannon’s diversity of replicon profiles indicated that the hypervirulent clones harbour less plasmid diversity than either of the unassigned or MDR clones (not driven solely by CG23, see Fig 5D, S9 Fig, Wilcoxon Rank Sum tests: hypervirulent vs MDR, p = 0.0013; hypervirulent vs unassigned, p = 0.0015; MDR vs unassigned, p = 0.44). Note that sample size was also significantly associated with plasmid replicon diversity (p = 0.017) but that both variables remained significant in a combined model (p<0.023, see S1 Text and S3 Table). Similar trends were seen for effective Shannon’s diversity of mob types but the differences were not statistically significant after Bonferroni correction for multiple testing (n = 3 tests), a finding that is not surprising given that far fewer mob types have been defined and that only ~48% completely sequenced Enterobacteriaceae plasmids deposited in GenBank could be mob typed (whereas ~83% could be replicon typed).
While these data are subject to the biases of the underlying databases within which clinically relevant (MDR and virulence) plasmids are overrepresented, they are also consistent with the findings above regarding overall pan-genome diversity. These data imply that MDR and unassigned clones frequently acquire and lose plasmids, consistent with the high plasmid diversity reported previously for ST258 and several others, and with data from recent investigations of K. pneumoniae circulating in hospitals which showed that individual plasmids transferred frequently between clones.
In contrast, the data showed that hypervirulent clones were associated with comparatively low plasmid diversity, mirrored by generally narrow plasmid load distributions (with CG25 as a putative exception, see S1 Text). Taken together these data imply that hypervirulent clones acquire novel plasmids infrequently but can stably maintain them. For example, as noted above we recently estimated that the virulence plasmid, which by definition is highly prevalent in these clones, has been maintained for >100 years in CG23. In addition, laboratory passage experiments have shown that hypervirulent strains can maintain MDR plasmids introduced in vitro, and we showed that a horse-associated subclade of CG23 has maintained a single MDR plasmid for at least 20 years.
The data also indicate that MDR clones may carry higher numbers of plasmids than either unassigned or hypervirulent clones. In vitro studies with Escherichia coli have shown that the relative fitness cost of a single plasmid can vary in a strain-dependent manner. Hence it is possible that the higher plasmid loads detected here in MDR K. pneumoniae clones reflect a lower cost of plasmid carriage, perhaps due to compensatory mutation(s) on the chromosome e.g. in DNA helicase and RNA polymerase genes as have been shown to influence plasmid carriage in Pseudomonas.
The polysaccharide capsule as a constraint on horizontal gene transfer
The combination of infrequent plasmid acquisitions and limited chromosomal recombination suggests that hypervirulent clones may be subject to particular constraints on DNA uptake and/or integration. One possible explanation is that these K. pneumoniae clones possess enhanced defences against incoming DNA such as CRISPR/Cas or restriction-modification (R-M) systems. However, our genome data reveals no significant differences in either system (see S1 Text, S10–S13 Figs). Alternatively, the key virulence determinants themselves, or other proteins encoded on the virulence plasmid, may play a role. Two variants of the virulence plasmid predominate among hypervirulent clones and share limited homology aside from the iuc, iro and rmpA loci. It seems unlikely that a siderophore system would influence DNA uptake, however it is conceivable that upregulation of capsule expression by rmpA may play a role by exacerbating the inhibitory effect of the capsule.
Capsule expression has been associated with a comparative reduction in K. pneumoniae transformation frequency in vitro and in a natural Streptococcus pneumoniae population. Additionally, the capsule is known to conceal the LPS which, together with the OmpA porins, are considered key target sites for attachment of conjugative pili during the initial phases of mate-pair formation. Hence we speculate that overexpression of the capsule in hypervirulent clones may result in a reduction of DNA uptake. Given that capsule types differ substantially in their thickness and polysaccharide composition, it is also likely that their influence on DNA uptake is type dependent. The K2 capsule, which is associated with five of the 6 hypervirulent clones investigated here is considered among the thicker capsule types and thus may have a comparatively greater influence. We used our genome data to test this hypothesis by comparing the genomic diversity of KL2 and non-KL2 genomes within MDR CG15, the only clone with sufficient KL2 and non-KL2 genomes for comparison. CG15-KL2 genomes formed a deep branching monophyletic subclade consistent with long-term maintenance of KL2 for an estimated 34 years (see S1 Text, and S14 and S15 Figs). This KL2 subclade showed a low rate of recombination compared to the rest of the clone (r/m 0.58 vs 6.75). The distribution of pairwise Jaccard gene distances also supported lower gene content diversity among the CG15-KL2 subclade (p < 1x10-12), as did the pan-genome curve alpha values (CG15-KL2; 0.785 vs CG15-other; 0.686), but this was not supported by the pan-genome PCA analysis (p = 0.2451, S1 Text and S14 Fig). Thus the genome data provide some support for our hypothesis that should motivate future laboratory studies of this phenomenon; a task that will not be trivial given the low efficiency of in vitro transformation for wild-type K. pneumoniae strains, the challenge of identifying suitable selective markers for distinguishing MDR strains, and the sensitivity of conjugation efficiencies to laboratory growth conditions. If true, this would imply that hypervirulent clones are evolutionarily constrained by a key determinant of the hypervirulent phenotype, and as such are self-limited in their ability to adapt to antimicrobial pressure.
Conversely, it is possible that the differences identified here do not reflect a mechanistic barrier for DNA uptake in hypervirulent clones, but rather ecological characteristics and/or mechanistic features common to MDR or unassigned clones (e.g. exposure to unique selective pressures due to preference for a specific ecological niche or enhanced tolerance of plasmid fitness costs, as discussed above). In particular, the former may also explain the elevated phage load and diversity in the MDR clones compared to either the hypervirulent or unassigned clones. However, as discussed above there are currently insufficient data to address these hypotheses.
Conclusions
Regardless of the mechanisms, our data clearly show that hypervirulent K. pneumoniae clones are less diverse than their MDR counterparts, and suggest that the rate of virulence plasmid acquisition by MDR clones will far exceed the rate of MDR plasmid acquisition by hypervirulent clones. This is particularly worrying from a hospital infection control perspective since many of the MDR clones investigated here appear well adapted to transmission and colonisation in the human population, and are frequent causes of hospital outbreaks. Given the mounting evidence that MDR clones can carry multiple plasmids at limited fitness cost and frequently exchange plasmids with other bacteria, it seems these MDR clones may also be the perfect hosts for consolidation and onwards dissemination of MDR and virulence determinants. The greatest concern is that these determinants will be consolidated onto a single mobile genetic element; indeed mosaic K. pneumoniae plasmids carrying AMR genes plus iuc and rmpA2 have already been reported in two MDR K. pneumoniae clones, and Escherichia coli plasmids bearing iuc, rmpA and AMR genes have been detected in K. pneumoniae. Whether these convergent strains and plasmids are fit and disseminating is not known. Recent experience with convergent carbapenem-resistant CG258 in China–which retrospective surveillance studies showed was already widely disseminated at the time of the outbreak report–highlights the ease with which deadly strains can circulate unnoticed. As reports of convergent K. pneumoniae strains continue to increase, the need for global genomic surveillance encompassing clone, AMR and virulence locus information is clearly greater than ever.
Genome collection and clone definition
We collected and curated 2265 K. pneumoniae genomes, comprising 647 genomes sequenced and published previously by our group plus 1623 publicly available genomes as described previously. Genomes were assigned to chromosomal multi-locus sequence types (MLST, as below), and a single representative of each sequence type (ST, n = 509) was selected for initial phylogenetics to define clones for further analysis. Sequence reads were mapped to the NTUH-K2044 reference chromosome (accession: NC_012731) using Bowtie v2 and single nucleotide variants were identified with SAMtools v1.3.1 as implemented in the RedDog pipeline (https://github.com/katholt/RedDog). Where genomes were available only as de novo assemblies, sequence reads were simulated using SAMtools wgsim (n = 852 genomes, for each of which 2 million x 100bp PE reads were simulated without errors). Allele calls were filtered to exclude sites that did not meet the following quality criteria: unambiguous consensus base calls, phred quality ≥30, depth ≥5 reads but <2-fold mean read depth, no evidence of strand bias. Subsequently, we generated a variable site alignment by concatenating nucleotides at core genome positions, i.e. at positions for which ≥95% genomes contained a base-call with phred quality ≥20 as we have described previously. The resulting alignment of 192,433 variable sites was used to infer a maximum likelihood phylogeny with FastTree v2.1.9 (gamma distribution of rate heterogeneity among sites, Fig 1A). Genomes were clustered into 259 phylogenetic lineages (clones) using patristic distance (distance threshold = 0.04). This threshold was selected because the resulting clusters included groups of STs that have been recognised as distinct clonal groups in previous genomics studies and are considered in the literature as cohesive groups that can be distinguished by their clinical behaviours e.g. causing hypervirulent vs opportunistic infections. A total of 29 clones (clonal groups, CGs) were identified that were each represented by ≥10 isolates from at least three different countries. One of these (CG82) was subsequently excluded because it uniquely included only historical isolate genomes (dated 1932–1949 or unknown). The remaining 28 clones (totalling 1092 genomes) were subjected to comparative analysis in this study. We refer to each as CGX, where X is the predominant ST in the clone, as per the convention for K. pneumoniae.
For each clone of interest, reads were mapped to a completed chromosomal reference genome belonging to that clone (see S1 Table and below), and variant calling and phylogenetic inference was performed as above. Phylogenies were manually inspected alongside genome source information to identify and de-duplicate clusters of closely related genomes from the same patient and/or known hospital outbreaks. Additional random sub-sampling was applied to CG258, which was otherwise drastically overrepresented in the collection (>700 genomes subsampled to 266 genomes). The final set of clones and genomes used for analyses are listed in S1 and S2 Tables, respectively.
Note that for the investigations of virulence and AMR determinant distributions in the broader K. pneumoniae population (shown in S2 Fig) we considered an independent subset of the original curated genome collection (n = 1124). This subset was described previously and was considered more representative of the population diversity because known outbreaks and overrepresented sequence types were subsampled.
Clonal reference genome selection
Reference genomes for each clone were identified among publicly available completed K. pneumoniae chromosome sequences for each ST represented in the clones of interest. Where there was no suitable publicly available reference genome we selected a representative isolate from our collection, for which Illumina data were available, and generated additional long read sequence data for completion of the genome through hybrid genome assembly (details below). The exception was CG380 for which no suitable reference was publicly available and for which we did not have access to any isolates in our collection. As such, we generated a pseudo-chromosomal reference by scaffolding the de novo assembly contigs for genome SRR2098675 (the CG380 genome with the lowest number of contigs) to the most closely related completed genome in our initial phylogeny (NCTC9136, available via the NCTC3000 genomes project website: http://www.sanger.ac.uk/resources/downloads/bacteria/nctc/). Contigs were scaffolded using Abacas and manually inspected using ACT (contig coverage ≥20%).
Long read sequencing and hybrid genome assembly
Novel completed reference genomes were generated for 10 clones (CG25, CG29, CG36, CG253, CG43, CG45, CG152, CG230, CG231, CG661) for which Illumina data were available. Novel long read data were generated on the Pacific Biosciences platform for two isolates (CG231 strain MSB1_8A, and CG29 strain INF206), and an Oxford Nanopore Technologies MinION device for the remaining isolates as described previously. Long read sequence data were combined with the existing short read Illumina data to generate complete hybrid assemblies with Unicycler. The final completed assemblies were deposited in GenBank (accessions listed in S1 Table) and are available in Figshare (see below).
MLST, virulence and resistance gene screening
Chromosomal MLST, AMR and virulence genes were detected with SRST2 (or Kleborate, available at https://github.com/katholt/Kleborate, for typing assemblies when no sequence reads were available). Sequence reads were assembled de novo using SPAdes v3, and Kaptive v0.5.1 was used to determine K and O locus types from assemblies. K and O locus diversities were calculated using the R package Vegan v2.4.3. The indices were converted to effective values to enable direct comparison between clones using the formula described previously; effective Shannon diversity = exp(Shannon diversity).
Recombination detection
Recombination analysis was performed independently for each clone: single nucleotide variants were identified by mapping and variant calling against the clonal reference genome as above, and a pseudo-chromosomal alignment was used as input for Gubbins v2.0.0, with the weighted Robinson-Foulds convergence method and RAxML phylogeny inference. The Gubbins output files were used to calculate r/m and mean recombination counts per base, calculated over non-overlapping 1000 bp windows (relative to each clone-specific reference chromosome). Pairwise nucleotide divergence across clone-specific core genome regions was calculated for each pair of genomes within a clone before and after removal of putative recombinant regions.
Pan-genome, plasmid and phage analyses
The SPAdes derived genome assemblies were annotated with Prokka v1.11 and subjected to a pan-genome analysis with Roary v3.6.0 (BLASTp identity ≥95%, no splitting of ‘paralogs’). The resulting gene content matrix comprised 1092 genomes vs 39375 genes (after excluding 1070 core genes present in ≥95% genomes) was used to calculate pairwise Jaccard distances and as input for PCA with the Adegenet R package v2.0.1. Coordinates for 463 principal components (PC) were extracted, accounting for 95% of the variation in the sample. We calculated the Euclidean distance from each genome to its clone centroid (the vector of mean coordinate values for that clone, see S16 Fig), and compared the distributions of distances across clones. Pan-genome accumulation curves were visualised using the R package Vegan v2.4.3 and alpha values were calculated by fitting the linear model log(y) ~ β*log(x) where y is the number of unique genes accumulated upon addition of a new genome (median from 100 random permutations) and x is the number of genomes. Alpha is estimated as -β, as derived from Heap’s law.
Accessory genes were identified as those present in <95% of all 1092 genomes belonging to the 28 clones analysed as described previously. For each genome assembly within a clone, the accessory gene sequences were extracted and concatenated into a single multi-fasta file (one per clone) that was used as input for ancestral assignment by Kraken v0.10.6, run with the miniKraken database. For each clone the proportions of accessory genes assigned to distinct genera were used to calculate Shannon’s diversity indices using the R package Vegan v2.4.3.
Phage were identified from genome assemblies using VirSorter v1.0.3, with the highest confidence threshold. The resulting output includes a set of putative phage sequences in fasta format, in which we identified open reading frames (ORFs) using Prokka v1.11. The resulting ORF sequences were clustered into non-redundant phage gene sequences using CD-HIT-EST v4.6.1 (identity ≥95%). BLASTn was used to tabulate the presence/absence of each of the resulting phage genes within the putative phage sequences identified by VirSorter in each genome (identity ≥95%, coverage ≥95%). The resulting gene content matrix was used as input for PCA and centroid distance calculations as described above for all accessory genes.
Plasmid replicons defined in the PlasmidFinder database were identified from assemblies using BLASTn as per the authors’ guidelines. Identically distributed replicons were collapsed into a single entry to minimise the influence of multi-replicon plasmids. Plasmid mob types were identified by PSI-BLAST as previously described. Effective Shannon’s diversities were calculated for each clone based on the replicon and mob presence/absence matrices, using the R package Vegan v2.4.3 as described above.
CRISPR/Cas and restriction-modification systems
CRISPR arrays were identified from genome assemblies using the CRISPR Recognition Tool v1.2. The majority of genomes harboured no more than two arrays and hence those identified with >3 putative arrays were investigated manually to check for spurious identifications and/or identifications of single arrays split over multiple assembly contigs. Nucleotide sequences for the previously described K. pneumoniae cas genes were extracted from the NTUH-K2044 reference chromosome (accession: NC_012731.1). Genomes were screened for novel cas genes by HMM domain search using the domain profiles developed by Burstein and colleagues (HMMER v3.1b2, bit score ≥200). A representative set of putative novel cas genes was extracted from the genome of isolate INF256 (read accession: ERR1008719, genome assembly available in Figshare) and tBLASTx was used to detect the presence of NTUH-K2044- and INF256-like cas genes among all genomes (identity ≥85%, coverage ≥25%). Note that the INF256 cas genes were subsequently found to be highly similar to those of strain Kp52.145 reported during the course of this study.
Putative restriction enzymes (REases) were identified from genome assemblies by HMM domain search using the domain profiles developed previously, parameters as above. CD-HIT v4.6.1 was used to cluster the predicted amino acid sequences of these REases such that distinct clusters represented enzymes that are thought to recognise distinct methylated nucleotide motifs; i.e. using amino acid identity thresholds of 80% identity for type I and type III REases; 55% identity for type II REases. To date no suitable threshold has been determined for type IV REases and thus in order to include type IV enzymes in our analyses we used the more conservative 55% identity threshold. Type IIC REase sequences cannot be aligned and were therefore excluded from the analysis. Nucleotide sequences for a single representative of each REase cluster were used to search all assemblies by BLASTn (identity ≥80%, coverage ≥90%). Only the single best hit was recorded for each region of each genome. In order to assess the DNA recipient potential of each genome, we also used BLASTn to screen a broader sample of the K. pneumoniae population, comprising the 1124 representative non-redundant genomes from our curated collection as described above and previously, plus a further 598 diverse K. pneumoniae genomes published during the course of this project. A putative donor-recipient pairing was considered compatible if the complete set of REases in the recipient genome were also present in the donor genome (we assume that genomes positive for an REase also carry the corresponding methyltransferase).
Investigating the impact of the K2 capsule on CG15 recombination and pan-genome diversity
K loci were overlaid onto the CG15 recombination-free maximum likelihood phylogeny, revealing that the KL2 locus was restricted to one of two major subclades (shaded blue and grey in S14 Fig). Recombination dynamics and pan-genome diversity were investigated separately for each of these subclades, using the methods described above. We used BEAST2 to estimate the time to most recent common ancestor (tMRCA) of the KL2 subclade, using as input the recombination-free single nucleotide variant alignment generated by Gubbins (2967 bp). The final analysis included 21 genomes (those for which years of collection were not known were excluded, see S2 Table) and was completed as described previously. Temporal structure was confirmed by date-randomisation tests, which showed that the evolutionary rate derived from the true data did not overlap those derived from any of 20 independent randomisations (S15 Fig).
References 109
- 1.
Holt KE, Wertheim H, Zadoks RN, Baker S, Whitehouse CA, Dance D, et al Genomic analysis of diversity, population structure, virulence, and antimicrobial resistance in Klebsiella pneumoniae, an urgent threat to public health. Proc Natl Acad Sci U S A. 2015;112: E3574–81.
Not in our library10.1073/pnas.1501049112
- 2.
- 3.
- 4.
Navon-Venezia S, Kondratyeva K, Carattoli A. Klebsiella pneumoniae: A major worldwide source and shuttle for antibiotic resistance. FEMS Microbiol Rev. 2017;41: 252–275.
Not in our library10.1093/femsre/fux013
- 5.
Wyres KL, Holt KE. Klebsiella pneumoniae population genomics and antimicrobial-resistant clones. Trends Microbiol. 2016;24: 944–956.
Not in our library10.1016/j.tim.2016.09.007
- 6.
Chen L, Mathema B, Chavda KD, DeLeo FR, Bonomo RA, Kreiswirth BN. Carbapenemase-producing Klebsiella pneumoniae: Molecular and genetic decoding. Trends Microbiol. 2014;22: 686–696.
Not in our library10.1016/j.tim.2014.09.003
- 7.
- 8.
- 9.
- 10.
Cortés G, Borrell N, Astorza D, Gómez C, Sauleda J, Albertí S. Molecular analysis of the contribution of the capsular polysaccharide and the lipopolysaccharide O side chain to the virulence of Klebsiella pneumoniae in a murine model of pneumonia. Infect Immun. 2002;70: 2583–2590.
Not in our library10.1128/iai.70.5.2583-2590.2002
- 11.
Sellick JA, Russo TA. Getting hypervirulent Klebsiella pneumoniae on the radar screen. Curr Op Microbiol. 2018;
Not in our library10.1097/qco.0000000000000464
- 12.
- 13.
- 14.
Kabha K, Nissimov L, Athamna A, Keisari Y, Parolis H, Parolis LA, et al Relationships among capsular structure, phagocytosis, and mouse virulence in Klebsiella pneumoniae. Infect Immun. 1995;63: 847–852.
Not in our library10.1128/iai.63.3.847-852.1995
- 15.
Wacharotayankun R, Arakawa Y, Ohta M, Tanaka K, Akashi T, Mori M, et al Enhancement of extracapsular polysaccharide synthesis in Klebsiella pneumoniae by RmpA2, which shows homology to NtrC and FixJ. Infect Immun. 1993;61: 3164–3174.
Not in our library10.1128/iai.61.8.3164-3174.1993
- 16.
Hsu CR, Lin TL, Chen YC, Chou HC, Wang JT. The role of Klebsiella pneumoniae rmpA in capsular polysaccharide synthesis and virulence revisited. Microbiology. 2011;157: 3446–3457.
Not in our library10.1099/mic.0.050336-0
- 17.
Lu M-C, Chen Y-T, Chiang M-K, Wang Y-C, Hsiao P-Y, Huang Y-J, et al Colibactin contributes to the hypervirulence of pks+ K1 CC23 Klebsiella pneumoniae in mouse meningitis infections. Front Cell Infect Microbiol. 2017;7: 1–14.
Not in our library10.3389/fcimb.2017.00001
- 18.
Lai YC, Lin AC, Chiang MK, Dai YH, Hsu CC, Lu MC, et al Genotoxic Klebsiella pneumoniae in Taiwan. PLoS One. 2014;9: e96292
Not in our library10.1371/journal.pone.0096292
- 19.
Bachman MA, Oyler JE, Burns SH, Caza M, Lépine F, Dozois CM, et al Klebsiella pneumoniae yersiniabactin promotes respiratory tract infection through evasion of lipocalin 2. Infect Immun. 2011;79: 3309–3316.
Not in our library10.1128/iai.05114-11
- 20.
Hsieh P, Lin T, Lee C, Tsai S, Wang J. Serum‐induced iron‐acquisition systems and TonB contribute to virulence in Klebsiella pneumoniae causing primary pyogenic liver abscess. J Infect Dis. 2008;197: 1717–1727.
Not in our library10.1086/588383
- 21.
Russo TA, Olson R, MacDonald U, Metzger D, Maltese LM, Drake EJ, et al Aerobactin mediates virulence and accounts for increased siderophore production under iron-limiting conditions by hypervirulent (hypermucoviscous) Klebsiella pneumoniae. Infect Immun. 2014;82: 2356–2367.
Not in our library10.1128/iai.01667-13
- 22.
- 23.
Ramirez MS, Traglia GM, Lin DL, Tran T, Tolmasky ME. Plasmid-mediated antibiotic resistance and virulence in gram-negatives: the Klebsiella pneumoniae paradigm. Microbiol Spectr. 2014;2: 1–15.
Not in our library10.1128/microbiolspec.plas-0016-2013
- 24.
- 25.
- 26.
Xie Y, Tian L, Li G, Qu H, Sun J, Liang W, et al Emergence of the third-generation cephalosporin-resistant hypervirulent Klebsiella pneumoniae due to the acquisition of a self-transferable blaDHA-1-carrying plasmid by an ST23 strain. Virulence 2018;9: 838–844.
Not in our library10.1080/21505594.2018.1456229
- 27.
Turton JF, Payne Z, Coward A, Hopkins KL, Turton JA, Doumith M, et al Virulence genes in isolates of Klebsiella pneumoniae from the UK during 2016, including among carbapenemase gene-positive hypervirulent K1-ST23 and ‘non-hypervirulent’ types ST147, ST15 and ST383. J Med Microbiol. 2017;67: 118–128.
Not in our library10.1099/jmm.0.000653
- 28.
- 29.
Yao B, Xiao X, Wang F, Zhou L, Zhang X, Zhang J. Clinical and molecular characteristics of multi-clone carbapenem-resistant hypervirulent (hypermucoviscous) Klebsiella pneumoniae isolates in a tertiary hospital in Beijing, China. Int J Infect Dis. 2015;37: 107–112.
Not in our library10.1016/j.ijid.2015.06.023
- 30.
Gu D-X, Huang Y-L, Ma J-H, Zhou H-W, Fang Y, Cai J-C, et al Detection of colistin resistance gene mcr-1 in hypervirulent Klebsiella pneumoniae and Escherichia coli isolates from an infant with diarrhea in China. Antimicrob Agents Chemother. 2016;60: 5099–5100.
Not in our library10.1128/aac.00476-16
- 31.
Gu D, Dong N, Zheng Z, Lin D, Huang M, Wang L, et al A fatal outbreak of ST11 carbapenem-resistant hypervirulent Klebsiella pneumoniae in a Chinese hospital: a molecular epidemiological study. Lancet Infect Dis. 2017;3099: 1–10.
Not in our library10.1016/s1473-3099(17)30489-9
- 32.
Heinz E, Ejaz H, Bartholdson-Scott J, Wang N, Guanjaran S, Pickard D, et al Emergence of carbapenem, beta-lactamase inhibitor and cefoxitin resistant lineages from a background of ESBL-producing Klebsiella pneumoniae and K. quasipneumoniae highlights different evolutionary mechanisms. bioRxiv. 2018;
Not in our library10.1101/283291
- 33.
Chen L, Kreiswirth BN. Convergence of carbapenem-resistance and hypervirulence in Klebsiella pneumoniae. Lancet Infect Dis. 2018;18: 9–10.
Not in our library10.1016/s1473-3099(17)30517-0
- 34.
Magiorakos A, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, et al Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18: 268–281.
Not in our library10.1111/j.1469-0691.2011.03570.x
- 35.
- 36.
- 37.
Podschun R, Ullmann U. Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factors. Clin Microbiol Rev. 1998;11: 589–603. Available: http://www.ncbi.nlm.nih.gov/pubmed/9767057
Not in our library10.1128/cmr.11.4.589
- 38.
Wyres KL, Holt KE. Klebsiella pneumoniae as a key trafficker of drug resistance genes from environmental to clinically important bacteria. Curr Opin Microbiol. 2018;45: 131–139.
Not in our library10.1016/j.mib.2018.04.004
- 39.
Mostowy RJ, Holt KE. Diversity-generating machines: genetics of bacterial sugar-coating. Trends Microbiol. 2018;xx: 1–14.
Not in our library10.1016/j.tim.2018.06.006
- 40.
Lin TL, Hsieh PF, Huang YT, Lee WC, Tsai YT, Su PA, et al Isolation of a bacteriophage and its depolymerase specific for K1 capsule of Klebsiella pneumoniae: implication in typing and treatment. J Infect Dis. 2014;210: 1734–1744.
Not in our library10.1093/infdis/jiu332
- 41.
Rieger-Hug D, Stirm S. Comparative study of host capsule depolymerases associated with Klebsiella bacteriophages. Virology. 1981;113: 363–378.
Not in our library10.1016/0042-6822(81)90162-8
- 42.
Rodriguez-Valera F, Martin-Cuadrado A-B, Rodriguez-Brito B, Pasić L, Thingstad TF, Rohwer F, et al Explaining microbial population genomics through phage predation. Nat Rev Microbiol. 2009;7: 828–836.
Not in our library10.1038/nrmicro2235
- 43.
Bidewell CA, Williamson SM, Rogers J, Tang Y, Ellis RJ, Petrovska L, et al Emergence of Klebsiella pneumoniae subspecies pneumoniae as a cause of septicaemia in pigs in England. PLoS One. 2018;13: e0191958
Not in our library10.1371/journal.pone.0191958
- 44.
Comandatore F, Sassera D, Bayliss SC, Scaltriti E, Cao X, Gales A, et al Gene composition as a potential barrier to large recombinations in the bacterial pathogen Klebsiella pneumoniae. bioRxiv. 2018;
Not in our library10.1093/gbe/evz236
- 45.
- 46.
Tettelin H, Riley D, Cattuto C, Medini D. Comparative genomics: the bacterial pan-genome. Curr Op Microbiol. 2008 pp. 472–477.
Not in our library10.1016/j.mib.2008.09.006
- 47.
- 48.
- 49.
Carattoli A, Zankari E, Garciá-Fernández A, Larsen MV, Lund O, Villa L, et al PlasmidFinder and pMLST: in silico detection and typing of plasmids. Antimicrob Agents Chemother. 2014;58: 3895–3903.
Not in our library10.1128/aac.02412-14
- 50.
Orlek A, Phan H, Sheppard AE, Doumith M, Ellington M, Peto T, et al Ordering the mob: Insights into replicon and MOB typing schemes from analysis of a curated dataset of publicly available plasmids. Plasmid. 2017;91: 42–52.
Not in our library10.1016/j.plasmid.2017.03.002
- 51.
Francia MV, Varsaki A, Garcillán-Barcia MP, Latorre A, Drainas C, De La Cruz F. A classification scheme for mobilization regions of bacterial plasmids. FEMS Microbiol Rev. 2004;28: 79–100.
Not in our library10.1016/j.femsre.2003.09.001
- 52.
Chen L, Mathema B, Pitout JD, DeLeo FR, Kreiswirth BN. Epidemic Klebsiella pneumoniae ST258 Is a hybrid strain. MBio. 2014;5: e01355–14.
Not in our library10.1128/mbio.01355-14
- 53.
Martin J, Phan HTT, Findlay J, Stoesser N, Pankhurst L, Navickaite I, et al Covert dissemination of carbapenemase-producing Klebsiella pneumoniae (KPC) in a successfully controlled outbreak: long- and short-read whole-genome sequencing demonstrate multiple genetic modes of transmission. J Antimicrob Chemother. 2017;72: 3025–3034.
Not in our library10.1093/jac/dkx264
- 54.
- 55.
Porse A, Munck C, Sommer MOA. Survival and evolution of a large multidrug resistance plasmid in new clinical bacterial hosts. Molec Biol Evol. 2016; Advanced online publication.
Not in our library10.1093/molbev/msw163
- 56.
Loftie-Eaton W, Bashford K, Quinn H, Dong K, Millstein J, Hunter S, et al Compensatory mutations improve general permissiveness to antibiotic resistance plasmids. Nat Ecol Evol. Springer US; 2017;
Not in our library10.1038/s41559-017-0243-2
- 57.
Cheng HY, Chen YS, Wu CY, Chang HY, Lai YC, Peng HL. RmpA regulation of capsular polysaccharide biosynthesis in Klebsiella pneumoniae CG43. J Bacteriol. 2010;192: 3144–3158.
Not in our library10.1128/jb.00031-10
- 58.
Wei D, Yuminaga Y, Shi J, Hao J. Non-capsulated mutants of a chemical-producing Klebsiella pneumoniae strain. Biotechnol Lett. 2018;40: 679–687.
Not in our library10.1007/s10529-018-2524-5
- 59.
Chewapreecha C, Harris SR, Croucher NJ, Turner C, Marttinen P, Cheng L, et al Dense genomic sampling identifies highways of pneumococcal recombination. Nat Genet. 2014;46: 305–309.
Not in our library10.1038/ng.2895
- 60.
- 61.
Anthony KG, Sherburne C, Sherburne R, Frost LS. The role of the pilus in recipient cell recognition during bacterial conjugation mediated by F‐like plasmids. Mol Microbiol. 1994;13: 939–953.
Not in our library10.1111/j.1365-2958.1994.tb00486.x
- 62.
Pérez-Mendoza D, de la Cruz F. Escherichia coli genes affecting recipient ability in plasmid conjugation: Are there any? BMC Genomics. 2009;10: 71
Not in our library10.1186/1471-2164-10-71
- 63.
- 64.
Fournet-Fayard S, Joly B, Forestier C. Transformation of wild type Klebsiella pneumoniae with plasmid DNA by electroporation. J Microbiol Methods. 1995;24: 49–54.
Not in our library10.1016/0167-7012(95)00053-4
- 65.
- 66.
Löhr IH, Hülter N, Bernhoff E, Johnsen PJ, Sundsfjord A, Naseer U. Persistence of a pKPN3-like CTX-M-15-encoding IncFIIK plasmid in a Klebsiella pneumoniae ST17 host during two years of intestinal colonization. PLoS One. 2015;10: e0116516
Not in our library10.1371/journal.pone.0116516
- 67.
Buckner MMC, Saw HTH, Osagie RN, McNally A, Ricci V, Wand ME, et al Clinically relevant plasmid-host interactions indicate that transcriptional and not genomic modifications ameliorate fitness costs of Klebsiella pneumoniae carbapenemase-carrying plasmids. MBio. 2018;9: e02303–17.
Not in our library10.1128/mbio.02303-17
- 68.
Lam MMC, Wyres KL, Wick RR, Judd LM, Fostervold A, Holt KE, et al Convergence of virulence and multidrug resistance in a single plasmid vector in multidrug-resistant Klebsiella pneumoniae ST15. J Antimicrob Chemother. 2019; Advanced online publication.
Not in our library10.1093/jac/dkz028
- 69.
Du P, Zhang Y, Chen C. Emergence of carbapenem-resistant hypervirulent Klebsiella pneumoniae. Lancet Infect Dis. 2017;3099: 30629
Not in our library10.1016/s1473-3099(17)30625-4
- 70.
Lam MCC, Wick RR, Wyres KL, Holt KE. Kleborate: comprehensive genotyping of Klebsiella pneumoniae genome assemblies. 2018. Available: https://github.com/katholt/Kleborate
Not in our library
- 71.
- 72.
The HC, Karkey A, Thanh DP, Boinett CJ, Cain AK, Ellington M, et al A high-resolution genomic analysis of multidrug- resistant hospital outbreaks of Klebsiella pneumoniae. EMBO Molec Med. 2015;7: 227–239.
Not in our library10.15252/emmm
- 73.
Struve C, Roe CC, Stegger M, Stahlhut SG, Hansen DS, Engelthaler DM, et al Mapping the evolution of hypervirulent Klebsiella pneumoniae. MBio. 2015;6: 1–12.
Not in our library10.1128/mbio.00630-15.invited
- 74.
Stoesser N, Batty EM, Eyre DW, Morgan M, Wyllie DH, Del Ojo Elias C, et al Predicting antimicrobial susceptibilities for Escherichia coli and Klebsiella pneumoniae isolates using whole genomic sequence data. J Antimicrob Chemother. 2013;68: 2234–2244.
Not in our library10.1093/jac/dkt180
- 75.
- 76.
Wand ME, Baker KS, Benthall G, McGregor H, McCowen JWI, Deheer-Graham A, et al Characterization of pre-antibiotic era Klebsiella pneumoniae Isolates with respect to antibiotic/disinfectant susceptibility and virulence in Galleria mellonella. Antimicrob Agents Chemother. 2015;59: 3966–3972.
Not in our library10.1128/aac.05009-14
- 77.
Deleo FR, Chen L, Porcella SF, Martens CA, Kobayashi SD, Porter AR, et al Molecular dissection of the evolution of carbapenem-resistant multilocus sequence type 258 Klebsiella pneumoniae. Proc Natl Acad Sci U S A. 2014;111: 4988–4993.
Not in our library10.1073/pnas.1321364111
- 78.
Davis GS, Waits K, Nordstrom L, Weaver B, Aziz M, Gauld L, et al Intermingled Klebsiella pneumoniae populations between retail meats and human urinary tract infections. Clin Infect Dis. 2015;61: 892–899.
Not in our library10.1093/cid/civ428
- 79.
Langmead B, Salzberg SL. Fast gapped-read alignment with Bowtie 2. Nat Methods. 2012;9: 357–359.
Not in our library10.1038/nmeth.1923
- 80.
Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, et al The Sequence Alignment/Map format and SAMtools. Bioinformatics. 2009/06/10. 2009;25: 2078–2079. btp352 [pii]
Not in our library10.1093/bioinformatics/btp352
- 81.
Wyres KL, Gorrie C, Edwards DJ, Wertheim HFL, Hsu LY, Van Kinh N, et al Extensive capsule locus variation and large-scale genomic recombination within the Klebsiella pneumoniae clonal group 258. Genome Biol Evol. 2015;7
Not in our library10.1093/gbe/evv062
- 82.
Price MN, Dehal PS, Arkin AP. FastTree: computing large minimum evolution trees with profiles instead of a distance matrix. Mol Biol Evol. 2009;26: 1641–1650.
Not in our library10.1093/molbev/msp077
- 83.
Assefa S, Keane TM, Otto TD, Newbold C, Berriman M. ABACAS: algorithm-based automatic contiguation of assembled sequences. Bioinformatics. 2009;25: 1968–1969. btp347 [pii]
Not in our library10.1093/bioinformatics/btp347
- 84.
Carver TJ, Rutherford KM, Berriman M, MA R, Barrell BG, Parkhill J. ACT: the Artemis comparison tool. Bioinformatics. 2005;21: 3422–3423.
Not in our library10.1093/bioinformatics/bti553
- 85.
- 86.
- 87.
- 88.
- 89.
Bankevich A, Nurk S, Antipov D, Gurevich AA, Dvorkin M, Kulikov AS, et al SPAdes: a new genome assembly algorithm and its applications to single-cell sequencing. J Comput Biol. 2012;19: 455–477.
Not in our library10.1089/cmb.2012.0021
- 90.
- 91.
Oksanen J, Blanchet FG, Friendly M, Kindt R, Legendre P, McGlinn D, et al. vegan: community ecology package. R package v 2.4.3. 2017.
Not in our library
- 92.
Jost L. Entropy and diversity. Oikos. 2006;113: 363–375.
Not in our library10.1111/j.2006.0030-1299.14714.x
- 93.
Stamatakis A. RAxML-VI-HPC: maximum likelihood-based phylogenetic analyses with thousands of taxa and mixed models. Bioinformatics. 2006;22: 2688–2690.
Not in our library10.1093/bioinformatics/btl446
- 94.
Seemann T. Prokka: rapid prokaryotic genome annotation. Bioinformatics. 2014;30: 2068–2069.
Not in our library10.1093/bioinformatics/btu153
- 95.
Jombart T. Adegenet: A R package for the multivariate analysis of genetic markers. Bioinformatics. 2008;24: 1403–1405.
Not in our library10.1093/bioinformatics/btn129
- 96.
- 97.
- 98.
- 99.
Ostria-Hernández ML, Sánchez-Vallejo CJ, Ibarra JA, Castro-Escarpulli G. Survey of clustered regularly interspaced short palindromic repeats and their associated Cas proteins (CRISPR/Cas) systems in multiple sequenced strains of Klebsiella pneumoniae. BMC Res Notes. BioMed Central; 2015;8: 332
Not in our library10.1186/s13104-015-1285-7
- 100.
Burstein D, Harrington LB, Strutt SC, Probst AJ, Anantharaman K, Thomas BC, et al New CRISPR–Cas systems from uncultivated microbes. Nature. Nature Publishing Group; 2017;542: 237–241.
Not in our library10.1038/nature21059
- 101.
Eddy SR, Wheeler TJ, HMMER development team. HMMER3 Suite. 2015. Available: http://hmmer.org/
Not in our library
- 102.
Shen J, Lv L, Wang X, Xiu Z, Chen G. Comparative analysis of CRISPR-Cas systems in Klebsiella genomes. J Basic Microbiol. 2017; 1–12
Not in our library10.1002/jobm.201600589
- 103.
Oliveira PH, Touchon M, Rocha EPC. Regulation of genetic flux between bacteria by restriction–modification systems. Proc Natl Acad Sci U S A. 2016;113: 5658–5663.
Not in our library10.1073/pnas.1603257113
- 104.
Cury J, Jové T, Touchon M, Néron B, Rocha EP. Identification and analysis of integrons and cassette arrays in bacterial genomes. Nucleic Acids Res. 2016;44: 4539–4550.
Not in our library10.1093/nar/gkw319
- 105.
Henson SP, Boinett CJ, Ellington MJ, Kagia N, Mwarumba S, Nyongesa S, et al Molecular epidemiology of Klebsiella pneumoniae invasive infections over a decade at Kilifi County Hospital in Kenya. Int J Med Microbiol. Elsevier; 2017;307: 422–429.
Not in our library10.1016/j.ijmm.2017.07.006
- 106.
Runcharoen C, Moradigaravand D, Blane B, Paksanont S, Thammachote J, Anun S, et al Whole genome sequencing reveals high-resolution epidemiological links between clinical and environmental Klebsiella pneumoniae. Genome Med. 2017;9: 6
Not in our library10.1186/s13073-017-0397-1
- 107.
- 108.
Smit P, Stoesser N, Pol S, van Kleef E, Oonsilvilai M, Tan P, et al Transmission dynamics of hyper-endemic multi-drug resistant Klebsiella pneumoniae in a Southeast Asian neonatal unit: a longitudinal study with whole genome sequencing. Front Microbiol. 2018;9: 1197
Not in our library10.3389/fmicb.2018.01197
- 109.
Cited by papers we hold 14
- General Overview of Klebsiella pneumonia: Epidemiology and the Role of Siderophores in Its Pathogenicity · 2024No notice
- International and regional spread of carbapenem-resistant Klebsiella pneumoniae in Europe · 2024No notice
- Carbapenem-Resistant Klebsiella pneumoniae: Virulence Factors, Molecular Epidemiology and Latest Updates in Treatment Options · 2023No notice
- Genomic dissection of Klebsiella pneumoniae infections in hospital patients reveals insights into an opportunistic pathogen · 2022No notice
- Frequencies and characteristics of genome-wide recombination in Streptococcus agalactiae, Streptococcus pyogenes, and Streptococcus suis · 2022Not checked
- Klebsiella pneumoniae Biofilms and Their Role in Disease Pathogenesis · 2022Corrected
- A systematic analysis of hypermucoviscosity and capsule reveals distinct and overlapping genes that impact Klebsiella pneumoniae fitness · 2021No notice
- A genomic surveillance framework and genotyping tool for Klebsiella pneumoniae and its related species complex · 2021No notice
- Virulence Factors in Hypervirulent Klebsiella pneumoniae · 2021No notice
- Finding Order in the Chaos: Outstanding Questions in Klebsiella pneumoniae Pathogenesis · 2021No notice
- Mobilization of the nonconjugative virulence plasmid from hypervirulent Klebsiella pneumoniae · 2021No notice
- The Small Protein RmpD Drives Hypermucoviscosity in Klebsiella pneumoniae · 2020No notice
- Community- and Hospital-Acquired <i>Klebsiella pneumoniae</i> Urinary Tract Infections in Portugal: Virulence and Antibiotic Resistance · 2019Not checked
- Klebsiella variicola : an emerging pathogen in humans · 2019No notice
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.